Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Introducing neoadjuvant chemotherapy (NCT) in a breast cancer patient may be associated with changes in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth hormone receptor 2 (HER2) status.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Forum of clinical oncology 2021-05, Vol.12 (1), p.3-11
Hauptverfasser: Taha, Heba F., Elfarargy, Ola M., Salem, Reham A., Mandour, Doaa, Salem, Amira A., Riad, Mohamed
Format: Artikel
Sprache:eng
Schlagworte:
Breast cancer
concordance between ER
HER2 neu
neoadjuvant chemotherapy
prognosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introducing neoadjuvant chemotherapy (NCT) in a breast cancer patient may be associated with changes in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth hormone receptor 2 (HER2) status.
ISSN:1792-362X
1792-362X
DOI:10.2478/fco-2019-0021